Analyst Ratings For NYSE:EVH – Evolent Health (NYSE:EVH)
Today, NYSE:EVH – Evolent Health (NYSE:EVH) stock was downgraded by JPMorgan Chase from Overweight to Neutral with a price target of $17.00.
Some recent analyst ratings include
- 4/24/2018-JPMorgan Chase was Downgraded by analysts at JPMorgan Chase from a “Overweight ” rating to a ” Neutral” rating. They now have a $17.00 price target on the stock.
- 1/4/2018-Citigroup initiated coverage with a Buy rating.
- 12/3/2017-Cantor Fitzgerald Reiterated Rating of Buy.
Recent Insider Trading Activity For NYSE:EVH – Evolent Health (NYSE:EVH)
NYSE:EVH – Evolent Health (NYSE:EVH) has insider ownership of 8.79% and institutional ownership of 99.71%.
- On 3/1/2018 Unitedhealth Group Inc, Director, sold 3,040,000 with an average share price of $13.70 per share and the total transaction amounting to $41,648,000.00.
- On 8/3/2017 Frank J. Williams, CEO, sold 16,300 with an average share price of $23.73 per share and the total transaction amounting to $386,799.00.
- On 8/1/2017 Steve Wigginton, CEO, sold 6,000 with an average share price of $24.64 per share and the total transaction amounting to $147,840.00.
- On 7/24/2017 Thomas Peterson III, COO, sold 40,540 with an average share price of $26.00 per share and the total transaction amounting to $1,054,040.00.
- On 7/10/2017 Nicholas Mcgrane, CFO, sold 1,667 with an average share price of $25.42 per share and the total transaction amounting to $42,375.14.
- On 7/6/2017 Frank J. Williams, CEO, sold 16,300 with an average share price of $24.76 per share and the total transaction amounting to $403,588.00.
- On 7/3/2017 Steve Wigginton, CEO, sold 6,000 with an average share price of $25.07 per share and the total transaction amounting to $150,420.00.
Recent Trading Activity for NYSE:EVH – Evolent Health (NYSE:EVH)
Shares of NYSE:EVH – Evolent Health closed the previous trading session at 16.45 down -0.20 1.20% with 319188 shares trading hands.
